|
Pankova E.D., Chulkov V.S., Ektova N.A.
Prognostication of non-alcoholic fatty liver disease in people of young age
|
№2 / 2024
|
|
Turkina S.V., Statsenko M.E., Kosivtsova M.A., Titarenko M.N., Tyshchenko I.A.
Patient with non-alcoholic fatty liver disease at care encounter of a therapist: Aspects of diagnostics and treatment
|
№9 / 2023
|
|
Tarasova L.V., Tsyganova Yu.V.
Therapy of non-alcoholic liver steatosis as an important factor in the prevention of complications of non-alcoholic fatty liver disease
|
№7 / 2023
|
|
Prikhodko V.A., Okovity S.V., Kulikov A.N.
Gliflozins in non-alcoholic fatty liver disease: Perspectives of use outside diabetes, cardiac and nephroprotection
|
№7 / 2023
|
|
Aryamkina O.L., Dobrynina I.Yu., Biek A.Yu., Saitov A.R., Tarasova L.V., Zapevalov A.V., Grishmanovsky P.V., Grishmanovskaya O.N.
Possibilities for diagnostics of non-alcoholic fatty liver disease in patients with metabolically associated comorbid pathology
|
№7 / 2023
|
|
Kislyak O.A., Mikaelyan A.A., Starodubova A.V., Kosyura S.D.
Cardiovascular and metabolic risks in patients with obesity and non-alcoholic fatty liver disease
|
№3 / 2023
|
|
Shulkina S.G., Erbes P.E., Smirnov E.N.
The contribution of the polymorphism of MMR 12 (rs652483) and PPARG (rs1801282) genes to the formation of NAFLD in obese patients
|
№10 / 2022
|
|
Prikhodko V.A., Okovity S.V.
Neuropsychiatric disorders of non-alcoholic fatty liver disease
|
№7 / 2022
|
|
Tarzimanova A.I.
The significance of non-alcoholic fatty liver disease in atrial fibrillation development: view of cardiologist
|
№5 / 2022
|
|
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment (clinical guidelines for therapists, third version)
|
№7 / 2021
|
|
Yagoda A.V., Geyvandova T.V., Rogova S.Sh., Geyvandova N.I.
The clinical significance of blood leptin in patients with non-alcoholic fatty liver disease associated with obesity
|
№3 / 2019
|
|
Koroy P.V., Slyadnev S.A., Kravchenko Yu.A., Yagoda A.V.
Influence of metabolic syndrome on course of non-alcoholic fatty liver disease
|
№3 / 2019
|
Русский
